Addition of Kisqali to drug plan in Quebec expands access to treatment for metastatic breast cancer

19 September 2019 - Provincial reimbursement provides public access to treatment that may delay the progression of advanced breast cancer. ...

Read more →

Baby Pia: almost 1 million Belgians pay for life-saving drug

18 September 2019 - More than 950,000 Belgians have responded to a couple seeking €1.9m ($2m; £1.7m) to cover the ...

Read more →

Three-year-old Matilda's ability to walk is giving hope to those with spinal muscular atrophy

18 September 2019 - The disease, which has been described as motor neurone disease for children, is the leading cause of ...

Read more →

'A child's health should not be a postcode lottery': anger of cystic fibrosis sufferers forced to pay £20,000 for drug abroad

17 September 2019 - Patients have formed a buyers' club to source a version of Orkambi after the drug's manufacturer and ...

Read more →

News NHS England explores funding options for cystic fibrosis drug

17 September 2019 - NHS England is “committed to exploring and developing alternative routes” to enable people with cystic fibrosis ...

Read more →

Canada decides: Leading parties plan to tackle ways to make medicine affordable

16 September 2019 - Canadian voters will be hearing a lot about a new national prescription drug program to fill a ...

Read more →

Right to try ‘remains a bust,’ as many drug makers prefer FDA reviews

12 September 2019 - Despite the hubbub over the “right-to-try” law, a recent survey found that nearly half of drug ...

Read more →

The U.S. health care system found a way to make peanuts cost $4,200

13 September 2019 - A new, billion-dollar pharmaceutical to treat peanut allergies is up for approval. It’s simply peanut flour. ...

Read more →

Vertex announces new access agreement with Scottish Government for Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor)

12 September 2019 - Eligible patients in Scotland will immediately have access to Orkambi (lumacaftor/ivacaftor) and Symkevi (tezacaftor/ivacaftor) in combination with ...

Read more →

Medexus reports Health Quality Ontario recommends Gliolan for public reimbursement

12 September 2019 - Medexus Pharmaceuticals today announced that Health Quality Ontario, under the guidance of the Ontario Health Technology ...

Read more →

Batten disease treatment: parents win battle ahead of court date

11 September 2019 - Families of children with a rare degenerative disease have won their fight for funding for NHS ...

Read more →

In U.S. biosimilars run into more roadblocks

12 September 2019 - In a recent op-ed in the Wall Street Journal Peter Bach asks whether it's time to ...

Read more →

Public plans covered only 26% of the 491 new drugs approved by Health Canada from 2009 to 2018; national pharmacare is an empty promise for 23.2 million Canadians now covered by private plans

11 September 2019 - Two new studies confirm the abysmal state of access to innovative medicines in Canada’s publicly funded drug ...

Read more →

New rules will keep the best medications from desperate Canadians

12 September 2019 - One reaction to recent amendments to the rules of the federal Patented Medicine Prices Review Board, ...

Read more →

Immunotherapy a groundbreaking new cancer treatment, but prohibitively expensive

10 September 2019 - Dave Roberts is fighting for his life, and his doctor says there is only one option ...

Read more →